299 related articles for article (PubMed ID: 33157291)
1. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
[TBL] [Abstract][Full Text] [Related]
2. Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Kaasch AJ; Fätkenheuer G; Prinz-Langenohl R; Paulus U; Hellmich M; Weiß V; Jung N; Rieg S; Kern WV; Seifert H;
Trials; 2015 Oct; 16():450. PubMed ID: 26452342
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
Trials; 2019 May; 20(1):250. PubMed ID: 31046810
[TBL] [Abstract][Full Text] [Related]
4. Sequential oral antibiotic in uncomplicated Staphylococcus aureus bacteraemia: a propensity-matched cohort analysis.
Diego-Yagüe I; Mora-Vargas A; Vázquez-Comendador JM; Santamarina-Alcantud B; Fernández-Cruz A; Múñez-Rubio E; Gutiérrez-Villanueva A; Sanchez-Romero I; Moreno-Torres V; Ramos-Martínez A; Calderón-Parra J
Clin Microbiol Infect; 2023 Jun; 29(6):744-750. PubMed ID: 36773773
[TBL] [Abstract][Full Text] [Related]
5. Association between treatment duration and mortality or relapse in adult patients with Staphylococcus aureus bacteraemia: a retrospective cohort study.
Abbas M; Rossel A; de Kraker MEA; von Dach E; Marti C; Emonet S; Harbarth S; Kaiser L; Uçkay I
Clin Microbiol Infect; 2020 May; 26(5):626-631. PubMed ID: 31357013
[TBL] [Abstract][Full Text] [Related]
6. Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.
Willekens R; Puig-Asensio M; Ruiz-Camps I; Larrosa MN; González-López JJ; Rodríguez-Pardo D; Fernández-Hidalgo N; Pigrau C; Almirante B
Clin Infect Dis; 2019 Jul; 69(3):381-387. PubMed ID: 30351401
[TBL] [Abstract][Full Text] [Related]
7. An Automated, Pharmacist-Driven Initiative Improves Quality of Care for Staphylococcus aureus Bacteremia.
Wenzler E; Wang F; Goff DA; Prier B; Mellett J; Mangino JE; Bauer KA
Clin Infect Dis; 2017 Jul; 65(2):194-200. PubMed ID: 28379326
[TBL] [Abstract][Full Text] [Related]
8. Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries.
Ammerlaan H; Seifert H; Harbarth S; Brun-Buisson C; Torres A; Antonelli M; Kluytmans J; Bonten M;
Clin Infect Dis; 2009 Oct; 49(7):997-1005. PubMed ID: 19719417
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus bacteraemia--Nationwide assessment of treatment adequacy and outcome.
Asgeirsson H; Kristjansson M; Kristinsson KG; Gudlaugsson O
J Infect; 2011 May; 62(5):339-46. PubMed ID: 21402101
[TBL] [Abstract][Full Text] [Related]
10. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus - selective reporting of antibiogram results and its impact on antibiotic use: Interventional study with a reference group on the effect of switching from non-selective to selective antibiotic reporting.
Lestin-Bernstein F; Harberg R; Schumacher I; Briedigkeit L; Heese O; Biedermann K
Antimicrob Resist Infect Control; 2021 Nov; 10(1):157. PubMed ID: 34742320
[TBL] [Abstract][Full Text] [Related]
12. Mortality predictors of Staphylococcus aureus bacteremia: a prospective multicenter study.
Yilmaz M; Elaldi N; Balkan İİ; Arslan F; Batırel AA; Bakıcı MZ; Gozel MG; Alkan S; Çelik AD; Yetkin MA; Bodur H; Sınırtaş M; Akalın H; Altay FA; Şencan İ; Azak E; Gündeş S; Ceylan B; Öztürk R; Leblebicioglu H; Vahaboglu H; Mert A
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():7. PubMed ID: 26860463
[TBL] [Abstract][Full Text] [Related]
13. Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Smith JR; Frens JJ; Snider CB; Claeys KC
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):50-54. PubMed ID: 29153470
[TBL] [Abstract][Full Text] [Related]
14. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
[TBL] [Abstract][Full Text] [Related]
15. Reduction of 30-day death rates from Staphylococcus aureus bacteremia by mandatory infectious diseases consultation: Comparative study interventions with and without an infectious disease specialist.
Hadano Y; Kakuma T; Matsumoto T; Ishibashi K; Isoda M; Yasunaga H
Int J Infect Dis; 2021 Feb; 103():308-315. PubMed ID: 33278619
[TBL] [Abstract][Full Text] [Related]
16.
Berrevoets MAH; Kouijzer IJE; Slieker K; Aarntzen EHJG; Kullberg BJ; Oever JT; Bleeker-Rovers CP
J Nucl Med; 2019 Jul; 60(7):998-1002. PubMed ID: 30552202
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin MIC Does Not Predict 90-Day Mortality, Readmission, or Recurrence in a Prospective Cohort of Adults with Staphylococcus aureus Bacteremia.
Baxi SM; Clemenzi-Allen A; Gahbauer A; Deck D; Imp B; Vittinghoff E; Chambers HF; Doernberg S
Antimicrob Agents Chemother; 2016 Sep; 60(9):5276-84. PubMed ID: 27324762
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus aureus bacteremia in an Indian tertiary care hospital: observational study on clinical epidemiology, resistance characteristics, and carriage of the Panton-Valentine leukocidin gene.
Eshwara VK; Munim F; Tellapragada C; Kamath A; Varma M; Lewis LE; Mukhopadhyay C
Int J Infect Dis; 2013 Nov; 17(11):e1051-5. PubMed ID: 23891294
[TBL] [Abstract][Full Text] [Related]
19. Safe shortening of antibiotic treatment duration for complicated
Buis D; van Werkhoven CH; van Agtmael MA; Bax HI; Berrevoets M; de Boer M; Bonten M; Bosmans JE; Branger J; Douiyeb S; Gelinck L; Jong E; Lammers A; Van der Meer J; Oosterheert JJ; Sieswerda E; Soetekouw R; Stalenhoef JE; Van der Vaart TW; Bij de Vaate EA; Verkaik NJ; Van Vonderen M; De Vries PJ; Prins JM; Sigaloff K;
BMJ Open; 2023 Apr; 13(4):e068295. PubMed ID: 37085305
[TBL] [Abstract][Full Text] [Related]
20. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.
Lesens O; Methlin C; Hansmann Y; Remy V; Martinot M; Bergin C; Meyer P; Christmann D
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):890-6. PubMed ID: 14700403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
